Table 3.

Variables Associated With Treatment Discontinuation for Inefficacy or Adverse Event

Variable	Univariable Cox Regression			Multivariable Cox Regression
	Hazard Ratio	95% CI	P	Hazard Ratio	95% CI	P
Disease duration	1.01	0.97–1.05	0.638
Duration of prior IFX exposure	0.99	0.90–1.09	0.884
Clinical remission at index switch	0.33	0.15–0.75	0.008	0.51	0.33–0.78	0.002
Immunomodulator at index switch	0.61	0.26–1.42	0.250
UC versus CD	1.27	0.78–2.09	0.339
Patient group
Originator to CT-P13	1			1
Originator to CT-P13 to SB2	0.39	0.14–1.11	0.077	0.33	0.11–0.94	0.038
CT-P13 to SB2	0.42	0.16–1.12	0.083	0.27	0.10–0.78	0.015